A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12
<p>Abstract</p> <p>Monoclonal antibodies represent some of the most promising molecular targeted immunotherapies. However, understanding mechanisms by which tumors evade elimination by the immune system of the host presents a significant challenge for developing effective cancer im...
Main Author: | Klinke David J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/242 |
Similar Items
-
Localized Interleukin-12 for Cancer Immunotherapy
by: Khue G. Nguyen, et al.
Published: (2020-10-01) -
An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer
by: Qing Wang, et al.
Published: (2020-01-01) -
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
by: Hong-My Nguyen, et al.
Published: (2020-02-01) -
Engineering persistent interleukin-2 for cancer immunotherapy
by: Gai, Shuning
Published: (2013) -
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
by: Jeffrey S Weber, et al.
Published: (2020-06-01)